Taysha Gene Therapies R&D Day: Clinical program updates on TSHA-120 under investigation for giant axonal neuropathy (GAN) and TSHA-102 under investigation for Rett syndrome
About The Event
Join us for a virtual R&D Day with Taysha Gene Therapies, who will discuss updates on the investigational TSHA-120 program in GAN and the investigational TSHA-102 program in Rett syndrome.
The event will feature collaborator Salman Bhai, MD (UT Southwestern Medical Center), who will discuss the unmet medical need, the current treatment landscape for GAN, and the comprehensive analyses of the totality of available data from the ongoing natural history and interventional trial evaluating the gene replacement therapy TSHA-120 in GAN. In addition, Taysha leadership will provide a clinical update on the TSHA-102 development program in Rett syndrome, including the active Phase 1/2 REVEAL Adult Study.
A live question and answer session will follow the formal presentations.